Jingli Shi

1.1k total citations
28 papers, 816 citations indexed

About

Jingli Shi is a scholar working on Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jingli Shi has authored 28 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jingli Shi's work include Inflammatory Myopathies and Dermatomyositis (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). Jingli Shi is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). Jingli Shi collaborates with scholars based in China and United States. Jingli Shi's co-authors include Qinglin Peng, Hanbo Yang, Guochun Wang, Yamei Zhang, Xudong Tang, Xin Lü, Shanshan Li, Xiaoming Shu, Shanshan Li and Guochun Wang and has published in prestigious journals such as Cancer Letters, Journal of Cellular Biochemistry and Oncotarget.

In The Last Decade

Jingli Shi

27 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingli Shi China 16 393 271 211 154 138 28 816
Lucia Picariello Italy 17 106 0.3× 277 1.0× 82 0.4× 65 0.4× 160 1.2× 24 976
Αthanasios Mavropoulos Greece 17 121 0.3× 243 0.9× 191 0.9× 48 0.3× 204 1.5× 40 1.0k
Ann Biehl United States 5 93 0.2× 231 0.9× 261 1.2× 59 0.4× 99 0.7× 8 970
Ling Lei China 14 75 0.2× 584 2.2× 58 0.3× 133 0.9× 160 1.2× 41 1.0k
Angéla Pákozdi United Kingdom 12 94 0.2× 194 0.7× 205 1.0× 74 0.5× 288 2.1× 23 736
Uǧur Akar United States 14 272 0.7× 571 2.1× 21 0.1× 82 0.5× 81 0.6× 26 1.0k
Yumi Yamaguchi Japan 19 117 0.3× 480 1.8× 55 0.3× 50 0.3× 89 0.6× 48 972
Hisashi Oku Japan 10 114 0.3× 285 1.1× 127 0.6× 666 4.3× 71 0.5× 12 1.1k
Hua Zhong China 16 90 0.2× 179 0.7× 121 0.6× 54 0.4× 90 0.7× 32 741
S Furuta Japan 15 289 0.7× 182 0.7× 59 0.3× 52 0.3× 61 0.4× 45 746

Countries citing papers authored by Jingli Shi

Since Specialization
Citations

This map shows the geographic impact of Jingli Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingli Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingli Shi more than expected).

Fields of papers citing papers by Jingli Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingli Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingli Shi. The network helps show where Jingli Shi may publish in the future.

Co-authorship network of co-authors of Jingli Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Jingli Shi. A scholar is included among the top collaborators of Jingli Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingli Shi. Jingli Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
6.
Das, Debasis, et al.. (2018). Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities – Part 1. Bioorganic & Medicinal Chemistry Letters. 29(4). 591–596. 49 indexed citations
7.
Zhang, Yamei, Hanbo Yang, Jingli Shi, et al.. (2018). The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy. Clinical Rheumatology. 37(6). 1573–1580. 12 indexed citations
8.
Chen, He, Qinglin Peng, Hanbo Yang, et al.. (2018). Increased Levels of Soluble Programmed Death Ligand 1 Associate with Malignancy in Patients with Dermatomyositis. The Journal of Rheumatology. 45(6). 835–840. 22 indexed citations
9.
Yang, Hanbo, Xin Lü, Qinglin Peng, et al.. (2018). Differential Clinical Associations of Anti–Nuclear Matrix Protein 2 Autoantibodies in Patients With Idiopathic Inflammatory Myopathies. Arthritis & Rheumatology. 70(8). 1288–1297. 18 indexed citations
10.
Chen, Fang, Shanshan Li, Tao Wang, Jingli Shi, & Guochun Wang. (2017). Clinical Heterogeneity of Interstitial Lung Disease in Polymyositis and Dermatomyositis Patients With or Without Specific Autoantibodies. The American Journal of the Medical Sciences. 355(1). 48–53. 27 indexed citations
11.
Zhou, Jia, Yixuan Zhao, Kai Liu, et al.. (2017). Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis. Oncotarget. 8(46). 80651–80665. 47 indexed citations
12.
Yang, Hanbo, Qinglin Peng, Shanshan Li, et al.. (2017). Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Research & Therapy. 19(1). 259–259. 123 indexed citations
13.
Shi, Jingli, Shanshan Li, Hanbo Yang, et al.. (2017). Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies. The Journal of Rheumatology. 44(7). 1051–1057. 121 indexed citations
14.
Zhan, Hongrui, et al.. (2016). Non-invasive treatment to grade 1 essential hypertension by percutaneous laser and electric pulse to acupoint with music: A randomized controlled trial. Chinese Journal of Integrative Medicine. 22(9). 696–703. 6 indexed citations
15.
Ge, Yongpeng, Hang Zhou, Jingli Shi, et al.. (2015). The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review. Clinical Rheumatology. 34(12). 2097–2103. 43 indexed citations
16.
17.
Li, He, Jingli Shi, Xiangyong Li, et al.. (2013). (−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α. Cancer Chemotherapy and Pharmacology. 71(3). 713–725. 43 indexed citations
18.
19.
Shi, Jingli, et al.. (2008). [Advances in Sertoli-Leydig cell tumour of the ovary].. PubMed. 37(9). 631–3. 1 indexed citations
20.
Wan, Lei, et al.. (2005). [Effects of the volatile oil of Centipeda minima on acute pleural effusion in rats induced by an intrapleural injection of car].. PubMed. 30(15). 1192–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia Picariello Breakdown of academic impact, for papers by Αthanasios Mavropoulos Breakdown of academic impact, for papers by Ann Biehl Breakdown of academic impact, for papers by Ling Lei Breakdown of academic impact, for papers by Angéla Pákozdi Breakdown of academic impact, for papers by Uǧur Akar Breakdown of academic impact, for papers by Yumi Yamaguchi Breakdown of academic impact, for papers by Hisashi Oku Breakdown of academic impact, for papers by Hua Zhong Breakdown of academic impact, for papers by S Furuta
Rankless by CCL
2026